Medicus Pharma issues 8,529,412 restricted shares in lieu of $1.45 million cash bonuses
MDCX•Exemption used for unregistered sale
The unregistered sale relied on the Securities Act Section 4(a)(2) private offering exemption.
No additional consideration received
No additional consideration was paid to, or received by, the company in the issuance.
Restricted shares issued for cash bonuses
Medicus Pharma issued 8,529,412 restricted common shares to officers and employees in lieu of about $1.45 million cash bonuses.
Shares were priced at $0.17 each, based on the Nasdaq closing price on Sept. 3, 2026.
